Logo image of COSMO.MI

FARMACOSMO SPA (COSMO.MI) Stock Fundamental Analysis

BIT:COSMO - Euronext Milan - IT0005487670 - Common Stock - Currency: EUR

0.552  +0 (+0.73%)

Fundamental Rating

2

COSMO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 51 industry peers in the Specialty Retail industry. Both the profitability and financial health of COSMO have multiple concerns. COSMO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year COSMO has reported negative net income.
In the past year COSMO has reported a negative cash flow from operations.
In multiple years COSMO reported negative net income over the last 5 years.
In the past 5 years COSMO reported 4 times negative operating cash flow.
COSMO.MI Yearly Net Income VS EBIT VS OCF VS FCFCOSMO.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

COSMO has a Return On Assets of -9.63%. This is amonst the worse of the industry: COSMO underperforms 80.39% of its industry peers.
COSMO has a worse Return On Equity (-28.08%) than 80.39% of its industry peers.
Industry RankSector Rank
ROA -9.63%
ROE -28.08%
ROIC N/A
ROA(3y)-7.87%
ROA(5y)-3.1%
ROE(3y)-21.54%
ROE(5y)9.09%
ROIC(3y)N/A
ROIC(5y)N/A
COSMO.MI Yearly ROA, ROE, ROICCOSMO.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1.3 Margins

Looking at the Gross Margin, with a value of 6.61%, COSMO is doing worse than 88.24% of the companies in the same industry.
In the last couple of years the Gross Margin of COSMO has grown nicely.
The Profit Margin and Operating Margin are not available for COSMO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.63%
COSMO.MI Yearly Profit, Operating, Gross MarginsCOSMO.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4 6

More info and screens

3

2. Health

2.1 Basic Checks

COSMO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for COSMO remains at a similar level compared to 1 year ago.
Compared to 5 years ago, COSMO has more shares outstanding
COSMO has a worse debt/assets ratio than last year.
COSMO.MI Yearly Shares OutstandingCOSMO.MI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M
COSMO.MI Yearly Total Debt VS Total AssetsCOSMO.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

COSMO has an Altman-Z score of 2.28. This is not the best score and indicates that COSMO is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.28, COSMO is in line with its industry, outperforming 50.98% of the companies in the same industry.
A Debt/Equity ratio of 0.63 indicates that COSMO is somewhat dependend on debt financing.
The Debt to Equity ratio of COSMO (0.63) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Altman-Z 2.28
ROIC/WACCN/A
WACC6.97%
COSMO.MI Yearly LT Debt VS Equity VS FCFCOSMO.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

A Current Ratio of 1.44 indicates that COSMO should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.44, COSMO is in the better half of the industry, outperforming 68.63% of the companies in the same industry.
A Quick Ratio of 0.70 indicates that COSMO may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.70, COSMO is in the better half of the industry, outperforming 64.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 0.7
COSMO.MI Yearly Current Assets VS Current LiabilitesCOSMO.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

5

3. Growth

3.1 Past

COSMO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.05%, which is quite good.
The Revenue for COSMO has decreased by -11.52% in the past year. This is quite bad
COSMO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.99% yearly.
EPS 1Y (TTM)8.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.54%
Revenue 1Y (TTM)-11.52%
Revenue growth 3Y2.78%
Revenue growth 5Y20.99%
Sales Q2Q%-11.43%

3.2 Future

The Earnings Per Share is expected to grow by 41.42% on average over the next years. This is a very strong growth
COSMO is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.48% yearly.
EPS Next Y33.33%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.4%
Revenue Next 2Y13.48%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
COSMO.MI Yearly Revenue VS EstimatesCOSMO.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
COSMO.MI Yearly EPS VS EstimatesCOSMO.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 0 -0.02 -0.04 -0.06

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for COSMO. In the last year negative earnings were reported.
Also next year COSMO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
COSMO.MI Price Earnings VS Forward Price EarningsCOSMO.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of COSMO indicates a slightly more expensive valuation: COSMO is more expensive than 68.63% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 66.48
COSMO.MI Per share dataCOSMO.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

COSMO's earnings are expected to grow with 41.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for COSMO!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FARMACOSMO SPA

BIT:COSMO (7/16/2025, 7:00:00 PM)

0.552

+0 (+0.73%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.76%
Inst Owner ChangeN/A
Ins Owners15.29%
Ins Owner ChangeN/A
Market Cap19.19M
AnalystsN/A
Price Target1.35 (144.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.3
P/FCF N/A
P/OCF N/A
P/B 1.81
P/tB N/A
EV/EBITDA 66.48
EPS(TTM)-0.08
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS1.81
BVpS0.3
TBVpS-0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.63%
ROE -28.08%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.61%
FCFM N/A
ROA(3y)-7.87%
ROA(5y)-3.1%
ROE(3y)-21.54%
ROE(5y)9.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3%
GM growth 5Y2.63%
F-Score4
Asset Turnover2.04
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF N/A
Debt/EBITDA 18.94
Cap/Depr 46.79%
Cap/Sales 1.95%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 0.7
Altman-Z 2.28
F-Score4
WACC6.97%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.05%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-39.54%
EPS Next Y33.33%
EPS Next 2Y41.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.52%
Revenue growth 3Y2.78%
Revenue growth 5Y20.99%
Sales Q2Q%-11.43%
Revenue Next Year10.4%
Revenue Next 2Y13.48%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y29.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year202.44%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y52.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.82%
OCF growth 3YN/A
OCF growth 5YN/A